领先的课程转型在药房教育中的课程转型
Sharon L Youmans1, Susan M Stein2
1UCSF School of Pharmacy, San Francisco, CA, USA.
American journal of pharmaceutical education
|November 8, 2025
概括
药房教育课程需要更新以满足现代需求. 这篇评论详细介绍了一项药学博士 (PharmD) 计划.
科学领域:
- 药房 教育 教育 药房 教育
- 课程开发 课程开发
- 高等教育教学的教学.
背景情况:
- 药房教育面临着对效率,有效性,经济性和相关性的压力.
- 准备药剂师应对21世纪的健康挑战,需要不断改进课程.
- 新兴技术,教学设计和成本影响药房教育.
研究的目的:
- 在药学博士 (PharmD) 计划中讨论课程修订过程.
- 分享经验和从重大计划变更中学到的经验和经验.
- 为适应未来需求的药房教育提供见解.
主要方法:
- 对课程修订的描述性评论.
- 分析程序长度,结构和评估的变化.
- 对实际实施和结果进行反思.
主要成果:
- 一个成熟的 PharmD 计划经历了实质性的课程改革.
- 修订涉及修改计划持续时间,组织结构和评估方法.
- 经验和从这个变革过程中学到的经验和教训被记录下来.
结论:
- 修改课程对于保持药学教育的相关性和有效性至关重要.
- 调整教育计划需要仔细考虑各种影响因素.
- 从这些修订中分享经验为其他机构提供了有价值的指导.
相关概念视频
Drug Administration and Therapy Phases: Overview
1.2K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.2K
Drug Biotransformation: Overview
3.5K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
3.5K
Drug Biotransformation: Overview
2.4K
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
2.4K
Biopharmaceutics and Pharmacokinetics: Overview
3.2K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
3.2K
Pharmacokinetics: Overview
8.8K
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
8.8K
Dosage Regimens: Designs and Approaches
248
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
248


